Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Neflamapimod TID	20
Overall Study	STARTED	Neflamapimod BID	26
Overall Study	STARTED	Placebo TID	27
Overall Study	STARTED	Placebo BID	18
Overall Study	COMPLETED	Neflamapimod TID	20
Overall Study	COMPLETED	Neflamapimod BID	20
Overall Study	COMPLETED	Placebo TID	26
Overall Study	COMPLETED	Placebo BID	15
Overall Study	NOT COMPLETED	Neflamapimod TID	0
Overall Study	NOT COMPLETED	Neflamapimod BID	6
Overall Study	NOT COMPLETED	Placebo TID	1
Overall Study	NOT COMPLETED	Placebo BID	3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04001517/flow